Michael Sofia
2019
In 2019, Michael Sofia earned a total compensation of $1.1M as Chief Scientific Officer at Arbutus Biopharma Corp.
Compensation breakdown
| Non-Equity Incentive Plan | $135,136 |
|---|---|
| Option Awards | $484,152 |
| Salary | $422,300 |
| Other | $9,800 |
| Total | $1,051,388 |
Sofia received $484.2K in option awards, accounting for 46% of the total pay in 2019.
Sofia also received $135.1K in non-equity incentive plan, $422.3K in salary and $9.8K in other compensation.
Rankings
In 2019, Michael Sofia's compensation ranked 9,063rd out of 13,971 executives tracked by ExecPay. In other words, Sofia earned more than 35.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,063 out of 13,971 | 35th |
Division Manufacturing | 3,633 out of 5,695 | 36th |
Major group Chemicals And Allied Products | 1,372 out of 2,194 | 38th |
Industry group Drugs | 1,169 out of 1,880 | 38th |
Industry Pharmaceutical Preparations | 864 out of 1,392 | 38th |
Source: SEC filing on April 24, 2020.
Sofia's colleagues
We found three more compensation records of executives who worked with Michael Sofia at Arbutus Biopharma Corp in 2019.
News
Arbutus Biopharma Corp CEO William Collier's 2023 pay jumps 28% to $3.4M
April 10, 2024
Arbutus Biopharma Corp CEO William Collier's 2022 pay slips 18% to $2.6M
April 12, 2023
Arbutus Biopharma Corp CEO William Collier's 2021 pay rises 18% to $3.2M
April 11, 2022
Arbutus Biopharma Corp CEO William Collier's 2020 pay rises 17% to $2.7M
April 8, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020